PTC Therapeutics Inc (PTCT)
36.38
+0.57
(+1.59%)
USD |
NASDAQ |
May 31, 16:00
36.31
-0.07
(-0.19%)
After-Hours: 20:00
PTC Therapeutics Debt to Equity Ratio: -0.3183 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | -0.3183 |
December 31, 2023 | -2.563 |
September 30, 2023 | -0.8545 |
June 30, 2023 | -0.9886 |
March 31, 2023 | -1.250 |
December 31, 2022 | -3.831 |
September 30, 2022 | -1.246 |
June 30, 2022 | -2.373 |
March 31, 2022 | -4.768 |
December 31, 2021 | 300.02 |
September 30, 2021 | 4.107 |
June 30, 2021 | 2.19 |
March 31, 2021 | 1.470 |
December 31, 2020 | 0.6414 |
September 30, 2020 | 0.593 |
June 30, 2020 | 0.5509 |
March 31, 2020 | 0.595 |
December 31, 2019 | 0.5281 |
September 30, 2019 | 0.4719 |
June 30, 2019 | 0.3186 |
March 31, 2019 | 0.3024 |
December 31, 2018 | 0.4363 |
September 30, 2018 | 0.3909 |
Date | Value |
---|---|
June 30, 2018 | 0.5567 |
March 31, 2018 | 0.9772 |
December 31, 2017 | 0.9267 |
September 30, 2017 | 0.9809 |
June 30, 2017 | 0.8322 |
March 31, 2017 | 0.9908 |
December 31, 2016 | 0.8213 |
September 30, 2016 | 0.6888 |
June 30, 2016 | 0.5732 |
March 31, 2016 | 0.4764 |
December 31, 2015 | 0.4064 |
September 30, 2015 | 0.3463 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.0004 |
September 30, 2013 | 0.0006 |
June 30, 2013 | 0.018 |
March 31, 2013 | 0.1125 |
December 31, 2012 | -0.2544 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.768
Minimum
Mar 2022
300.02
Maximum
Dec 2021
14.66
Average
0.3952
Median
Debt to Equity Ratio Benchmarks
Sarepta Therapeutics Inc | 1.289 |
Pfizer Inc | 0.7445 |
Biogen Inc | 0.4299 |
Catalyst Pharmaceuticals Inc | 0.00 |
Regenxbio Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.790B |
Total Liabilities (Quarterly) | 2.684B |
Shareholders Equity (Quarterly) | -893.92M |
Current Ratio | 2.034 |
Net Debt Paydown Yield | 9.37% |